What dose of omega-3 fatty acids is recommended for tapering off Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

1-2 g/day of total EPA from pure EPA or an EPA/DHA (>2:1) combination is recommended for tapering off Lexapro (escitalopram) as an adjunctive treatment for major depressive disorder (MDD) 1.

Key Considerations

  • The dose can be increased in 2 weeks for non- or partial responders and titrated up to the maximum dose in 4-6 weeks if tolerable.
  • It is essential to monitor adverse effects systematically, including gastrointestinal and dermatological conditions, and obtain a comprehensive metabolic panel in patients receiving higher doses of n–3 PUFAs.
  • Clinicians should evaluate the quality of n–3 PUFA supplementary products for nonresponders.

Important Details

  • Both pure EPA and EPA/DHA (ratio >2:1) combinations are effective as a potential treatment of MDD.
  • n–3 PUFAs are considered effective as an adjunctive treatment for acute major depressive episodes, but more evidence is needed for recurrent major depressive episodes 1.

Clinical Application

  • Clinicians should use n–3 PUFAs as an adjunctive treatment rather than monotherapy for adult MDD.
  • n–3 PUFAs can be used for acceleration (adding n–3 at the beginning of treatment concurrently with another antidepressant) or augmentation (adding n–3 when a prior antidepressant’s effect is inadequate).

From the Research

Omega-3 Fatty Acids and Lexapro (Escitalopram) Tapering

  • There is no direct evidence to support a specific dose of omega-3 fatty acids for tapering off Lexapro (escitalopram) 2, 3, 4, 5, 6.
  • However, studies have investigated the use of omega-3 fatty acids in combination with antidepressants, including escitalopram, for the treatment of depression:
    • A study found that combination therapy with citalopram (a related SSRI) and omega-3 fatty acids (1g/day) was effective in reducing depression symptoms in post-menopausal women 2.
    • Another study found that omega-3 fatty acid levels were not correlated with early responsiveness to escitalopram, but neuroticism was a predictor of improvement 3.
    • A randomized controlled trial found that combination therapy with citalopram and omega-3 fatty acids (2g/day) was more effective than monotherapy with citalopram in reducing depression symptoms 4.
  • The pharmacokinetics of escitalopram have been studied, but there is no specific guidance on tapering off the medication using omega-3 fatty acids 5.
  • Omega-3 fatty acids have been studied for their effects on hypertriglyceridemia, and the optimal dose for this condition is still debated 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.